Sigachi Industries Ltd
Sigachi Industries Ltd. (SIL) is one of the largest manufacturers of Microcrystalline Cellulose worldwide and has three Multi locational Facilities in Telangana and Gujarat.[1]
- Market Cap ₹ 1,948 Cr.
- Current Price ₹ 58.4
- High / Low ₹ 69.9 / 34.0
- Stock P/E 40.9
- Book Value ₹ 16.8
- Dividend Yield 0.17 %
- ROCE 13.4 %
- ROE 9.83 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
Cons
- Promoter holding has decreased over last quarter: -0.57%
- Company has a low return on equity of 12.2% over last 3 years.
- Promoters have pledged 44.0% of their holding.
- Dividend payout has been low at 5.13% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
81 | 102 | 128 | 139 | 188 | 249 | 290 | 318 | 408 | |
72 | 89 | 101 | 114 | 151 | 199 | 234 | 258 | 334 | |
Operating Profit | 9 | 12 | 27 | 25 | 37 | 50 | 56 | 59 | 74 |
OPM % | 11% | 12% | 21% | 18% | 20% | 20% | 19% | 19% | 18% |
1 | 3 | 4 | 5 | 3 | 3 | 7 | 12 | 20 | |
Interest | 4 | 4 | 3 | 2 | 1 | 1 | 4 | 7 | 11 |
Depreciation | 1 | 1 | 2 | 2 | 2 | 3 | 7 | 9 | 13 |
Profit before tax | 4 | 10 | 25 | 25 | 37 | 49 | 52 | 55 | 71 |
Tax % | 33% | 26% | 23% | 20% | 22% | 22% | 19% | 26% | 33% |
3 | 8 | 20 | 20 | 29 | 38 | 42 | 41 | 48 | |
EPS in Rs | 0.92 | 2.52 | 6.41 | 2.66 | 3.78 | 1.24 | 1.35 | 1.25 | 1.43 |
Dividend Payout % | 11% | 4% | 2% | 4% | 0% | 8% | 7% | 8% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 18% |
TTM: | 28% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 8% |
TTM: | 16% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 31% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 12% |
Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 38 |
Reserves | 17 | 24 | 43 | 59 | 87 | 196 | 235 | 377 | 521 |
28 | 29 | 24 | 28 | 21 | 35 | 68 | 135 | 113 | |
12 | 15 | 21 | 14 | 18 | 22 | 35 | 64 | 74 | |
Total Liabilities | 60 | 71 | 91 | 109 | 134 | 284 | 369 | 609 | 746 |
23 | 26 | 29 | 32 | 38 | 53 | 122 | 139 | 254 | |
CWIP | 1 | 1 | 2 | 3 | 4 | 10 | 35 | 91 | 5 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 102 | 102 |
36 | 45 | 60 | 74 | 92 | 221 | 210 | 276 | 385 | |
Total Assets | 60 | 71 | 91 | 109 | 134 | 284 | 369 | 609 | 746 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
9 | 7 | 15 | 12 | 28 | 5 | 28 | 15 | 36 | |
-2 | -4 | -6 | -7 | -11 | -63 | -93 | -158 | -90 | |
-6 | -4 | -9 | 3 | -9 | 108 | 26 | 163 | 70 | |
Net Cash Flow | 1 | -1 | -0 | 8 | 8 | 51 | -39 | 20 | 15 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 60 | 79 | 72 | 79 | 82 | 106 | 115 | 126 | 120 |
Inventory Days | 136 | 88 | 118 | 130 | 57 | 49 | 89 | 77 | 71 |
Days Payable | 61 | 50 | 45 | 37 | 29 | 28 | 54 | 69 | 61 |
Cash Conversion Cycle | 136 | 116 | 145 | 172 | 109 | 126 | 150 | 135 | 130 |
Working Capital Days | 99 | 94 | 106 | 131 | 109 | 135 | 142 | 158 | 177 |
ROCE % | 27% | 46% | 33% | 36% | 27% | 19% | 14% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Sigachi receives ToR for new 25-acre API and specialty chemicals facility in Andhra Pradesh.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
5 Jun - Sigachi Q4 FY25 earnings: 25% revenue growth, CCS plant by Oct 2026, strong margins, API and O&M growth outlook.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
31 May - Newspaper Publication of financial results for period ended 31.03.2025
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
30 May - Audio recording of Q4 FY 2024-25 earnings call available on company website.
-
Corporate Action-Board approves Dividend
30 May - Approved FY25 audited results; recommended Rs.0.10 dividend; approved Rs.37.22 Cr acquisition in Trimax Bio Sciences.
Annual reports
Concalls
-
Jun 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
Jan 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT REC
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Dec 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jul 2022Transcript PPT
-
May 2022Transcript PPT
Business Segments Q1 FY25